Overall these results support a role for Bcl-3 in the regulation of non-canonical and canonical NF-κB activity and Bcl-2 expression in mammary adenocarcinomas such that its absence results in preferential expansion of squamous tumors lacking both NF-κB activity and Bcl-2 expression. The gene discussed is NFKB1; the disease is breast adenocarcinoma.